Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests a possible link between FAM111B gene mutations and increased cancer risk, particularly pancreatic cancer.

An 18-year-old man was diagnosed with a rare genetic disorder causing hair loss, severe light sensitivity, and skin issues.

Valproic acid helps hair follicle stem cells survive better in low oxygen and glucose conditions.

The new drug delivery system effectively targets lung cancer cells.

Mushroom-based scaffolds help heal skin wounds and regrow hair.

GFC is more effective than PRP for treating hair loss.

Fluoxetine may help reduce fat by limiting stem cell growth and fat cell formation.

A genetic marker linked to a type of hair loss was found in most patients studied.

BcFLA1 protein is crucial for root hair growth in response to low phosphate in Brassica carinata.

Japanese cases of fibrosing alopecia show a unique age and hair loss pattern, possibly due to racial differences.

Family caregivers take longer to fall asleep and have more sleep disturbances, which may contribute to their health problems.

Higher SFRP-4 levels were found in people without a diabetic family history.

PRF is promising for dental and aesthetic uses but needs more research.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

Method measures tamsulosin and finasteride in medicine accurately.

FGF9 helps hair follicles grow in small-tailed Han sheep by affecting cell growth and certain signaling pathways.

Patients with Frontal fibrosing alopecia in Morocco often have skin conditions and thyroid disorders.

MAFT is a reliable method for forehead contouring with high patient satisfaction and long-term results.

Female pattern hair loss greatly harms women's mental health and social life.

GFC improves hair quickly, while PRP offers longer-lasting benefits; using both sequentially is recommended.

Hair transplants can trigger a rare scarring hair loss that is hard to treat.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Researchers should follow the FACE-Q User's Guide for accurate results.

The SAFE System may improve hair transplant results but isn't suitable for everyone.

Botulinum Toxin Type A delivered through the skin may be a promising treatment for Frontal Fibrosing Alopecia.

Most dermatologists think post-finasteride syndrome is rare, possibly psychiatric, and needs more research.

Topical sulforaphane reduces pigmentation and wrinkles from sun damage.